Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
- Published: November 2011
- Region: Global
BRICSS Market Watch:
The broad ‘health care' division has been witnessing a rapid growth and technological improvements varying from sector to sector since the past 3-5 years. The evolution of cardiac devices has opened new vistas in the health care industry. Growth rate exhibited by the cardiac devices industry, even during the recession years, confirms the positive growth prospects going ahead.
BRICSS Cardiac Defibrillators market forecasts to reach at US$1.7 billion by 2015 at a high CAGR of 9.5% during the analysis period 2009-2015. China accounts for more than 25% of the global value and India claims almost a closer value of the BRICSS market. In terms of CAGR, India is the fastest growing region while China and South Korea are just behind. Forecasts of BRICSS External Defibrillators market value depict nearly half of Implantable Cardioverter Defibrillator market by 2015. In terms of market value, biphasic technologies used in the sector are expected to double the worth of monophasic technologies 2015.
The report ‘Cardiac Defibrillators - Emerging Markets (Brazil, Russia, India, China, South Africa and South Korea), 2009-2015' reviews the latest trends in the cardiac defibrillators market with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for life science sector investments. The study reveals profitable investment strategies for pharmaceutical manufacturers, biotechnology companies, laboratories, Contract Research Organizations (CROs), government organizations and many more in preferred locations.
The report primarily focuses on:
- Emerging Market Trends
- Advancements in the Technological Space
- Market Demand Of The Segments (By-Region)
- Key Growth Areas and Market Size
- Region-Wise Demand Factor
- Key Competitors Edge
- Investment Strategies
The report covers the market analysis by product types and by technology. The subdivisions are as:
- By Product
a. Implantable Cardioverter Defibrillators (ICD)
b. External Defibrillating Devices ‘or' Automated External Defibrillator (AED)
- By Technology
The period considered for the market analysis is 2009-2015. The region wise distribution of the market consists of Emerging Markets Brazil, Russia, India, China, South Africa and South Korea. Incorporating the recession impacts on the industry, the market growth rate in these economies are estimated individually for the upcoming years.
More than 700 leading market players are identified and 95 key companies in cardiac medical devices industry that project improved market activities in the near future are profiled. The report consists of 75 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed.
Estimates are based on online surveys using customized questionnaires by our research team. Besides information from government databases, company websites, press releases & published research reports are also used for estimates. Estimates have incorporated recessionary impact on the cardiac devices industry. SHOW LESS READ MORE >
- Abbott Vascular Devicesatricure, Inc
- Abiomed, Inc.
- Advansource Biomaterials
- Aga Medical Corporation
- Atrium Medical Corp.
- Ats Medical, Inc.
- Biophan Technologies, Inc.
- Biosense Webster, Inc.
- Boston Scientific Corp.
- Cardiac Science Corp.
- Cardiacassist, Inc.
- Cardica, Inc.
- Cardiomems, Inc.
- Cook Group Incorporated
- Cordis Corporation
- Cryolife Inc.
- Idev Technologies
- Medtronic, Inc.
... and many more